Graves disease following radioiodine therapy for toxic adenoma: Clinical case report

RATIONALE: There is a low risk of developing Graves disease (GD) with elevated thyrotropin receptor antibodies (TRAbs) in patients undergoing radioiodine therapy for toxic adenoma. PATIENT CONCERNS: An old female patient with a history of Hashimoto thyroiditis was referred to our department due to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Guohua, Cui, Futao, Huang, Rui, Kuang, Anren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690762/
https://www.ncbi.nlm.nih.gov/pubmed/29137069
http://dx.doi.org/10.1097/MD.0000000000008550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690762/
https://www.ncbi.nlm.nih.gov/pubmed/29137069
http://dx.doi.org/10.1097/MD.0000000000008550

Ejemplares similares